Although most of these proteostatic diseases are predominantly intracellular, we have observed how cancer has extracellular Hsp90-dependent components, and the formation of toxic protein aggregates in neurodegenerative maladies also has consequences outside the cell. Here, HSP90AA1 is linked to cancer.